RxDoctor Payments DataLook up a doctor →

David Doriguzzi

Medical · Lancaster, CANPI 1730195728

Payments from drug & device makers

$514,249in general payments, 2019–2025

Across 3,082 payments — averaging $166.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$349K
  • Novo Nordisk$74K
  • Dexcom, Inc.$48K
  • Corcept Therapeutics$25K
  • Bayer$6K
  • Mannkind Corporation$4K
  • plus $9K from 35 others
$1,883in research payments, 2019–2025

Across 8 payments — averaging $235.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$2K

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$514,249 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California

Other medical in Lancaster

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →